Overall cancer incidence and mortality for kidney and other cancers up with severe psoriasis.
The use of steroids for the treatment of immune-related adverse events may have survival consequences.
Following nephrectomy for renal cell carcinoma with lymph node involvement, patients have a 5-year survival rate of only 28%, a new study found.
Updated follow-up of patients in the KEYNOTE-427 trial showed that first-line pembrolizumab for advanced clear cell renal cell carcinoma exerts favorable antitumor activity after a median 23 months of follow-up.
Active surveillance remains the standard of care for patients at intermediate or high risk of recurrence following nephrectomy.
Renal & Urology News interviewed Michael Crane, MD, MPH, director of the WTC Health Program at Mount Sinai hospital about cancers and other long-term health problems linked with the events of September 11, 2001.
Risk varies by cardiovascular outcome and site of 20 common cancers
Unmarried vs married men have lower rates of receiving cytoreductive nephrectomy, metastasectomy, and systemic therapy use, and unmarried vs married women have lower rates of cytoreductive nephrecotomy and systemic therapy use, a study found.
Superiority of the regimen was shown in intermediate- and poor-risk groups, as well as in intention-to-treat populations.
A retrospective study compared older patients with mRCC with younger ones to determine if age and potential comorbidities is a barrier to clinical trial participation.